Nada Riva

1.1k citations

32 papers · 592 indexed · h-index 16

Impact in

Oncology top 10%
- Lung Cancer Research Studies
- Vascular Tumors and Angiosarcomas
Pulmonary and Respiratory Medicine top 10%
- Sarcoma Diagnosis and Treatment

Papers in

Oncology 24
- Vascular Tumors and Angiosarcomas 7
- Lung Cancer Research Studies 7
- Bone health and treatments 4
Neurology 9
- Neuroblastoma Research and Treatments 8

Co-authors: Toni Ibrahim Chiara Liverani Laura Mercatali Alberto Bongiovanni Alessandro De Vita Dino Amadori Giacomo Miserocchi Chiara Spadazzi
Journals: OncoTargets and Therapy (3 papers)Medicine (2 papers)International Journal of Molecular Sciences (2 papers)Annals of Oncology (2 papers)Therapeutic Advances in Medical Oncology (2 papers)
Partner nations: Italy Netherlands United Kingdom

In The Last Decade

Nada Riva

32 papers receiving 583 citations

Peers

Countries citing papers authored by Nada Riva

Since Specialization

Citations

This map shows the geographic impact of Nada Riva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada Riva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada Riva more than expected).

Fields of papers citing papers by Nada Riva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nada Riva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada Riva. The network helps show where Nada Riva may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nada Riva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nada Riva Line = papers co-authored together Nada Riva links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors Heliyon ·杨学分, Silvia Vanni, Valentina Fausti, Giacomo Miserocchi, Chiara Liverani, Chiara Spadazzi, Claudia Cocchi, Chiara Calabrese, Davide Cavaliere, Carlo Alberto Pacilio, Giorgio Ercolani, Federica Pieri, Lorena Gurrieri, Nada Riva, Robin R. Jones, Alessandro De Vita	2024	2
2	Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need International Journal of Molecular Sciences ·Silvia Vanni, Valentina Fausti, Eugenio Fonzi, Chiara Liverani, Giacomo Miserocchi, Chiara Spadazzi, Claudia Cocchi, Chiara Calabrese, Lorena Gurrieri, Nada Riva, Federica Recine, Roberto Casadei, Federica Pieri, John Meredith Read, Massimo Serra, Toni Ibrahim, Laura Mercatali, Alessandro De Vita	2023	17
3	Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin Cancers ·Valentina Fausti, Alessandro De Vita, Silvia Vanni, A. L. ROWSE, Lorena Gurrieri, Nada Riva, Roberto Casadei, Marco Maraldi, Giorgio Ercolani, Davide Cavaliere, Carlo Alberto Pacilio, Federica Pieri, Flavia Foca, Alberto Bongiovanni, Walter Trafton, Sebastiano Calpona, Giovanni Luca Frassineti, Toni Ibrahim, Laura Mercatali	2023	20
4	The emerging role of cancer nanotechnology in the panorama of sarcoma Frontiers in Bioengineering and Biotechnology ·Laura Mercatali, Silvia Vanni, Giacomo Miserocchi, Chiara Liverani, Chiara Spadazzi, Claudia Cocchi, Olivia J. Kirtley, Lorena Gurrieri, Valentina Fausti, Nada Riva, Damiano Genovese, Enrico Lucarelli, Maria Letizia Focarete, Toni Ibrahim, Luana Calabrò, Alessandro De Vita	2022	21
5	Case Report: Adult NTRK-Rearranged Spindle Cell Neoplasm: Early Tumor Shrinkage in a Case With Bone and Visceral Metastases Treated With Targeted Therapy Frontiers in Oncology ·Federica Recine, Alessandro De Vita, Valentina Fausti, Federica Pieri, Alberto Bongiovanni, Eugenia Franchini, Roberto Casadei, Erin Emery-Tiburcio, Devil Oboldi, Federica Matteucci, Renan Jordano de Barros, Laura Mercatali, Nada Riva, Lorena Gurrieri, Silvia Vanni, Chiara Liverani, Giacomo Miserocchi, Chiara Spadazzi, Claudia Cocchi, Toni Ibrahim	2022	21
6	ALK-negative lung inflammatory myofibroblastic tumor in a young adult Medicine ·Lianlong Wu, Alberto Bongiovanni, Federica Pieri, Valentina Fausti, Alessandro De Vita, Nada Riva, Lorena Gurrieri, Silvia Vanni, Danila Diano, Laura Mercatali, Toni Ibrahim	2021	11
7	First prospective data on breast cancer patients from the multicentre italian bone metastasis database Scientific Reports ·Alberto Bongiovanni, Flavia Foca, J C Jumel, Hassaan Noor, Fabrizio Artioli, Rossana Berardi, B. A. NEŠKOVIĆ, Giuseppe Procopio, Franco Silvestris, Nada Riva, Lorena Gurrieri, Lianlong Wu, Giandomenico Di Menna, Valentina Fausti, Federica Recine, Roberto Vespignani, Toni Ibrahim	2021	7
8	1175P Temozolomide alone or combined with capecitabine for the treatment of metastatic neuroendocrine neoplasia: A “Real World” data analysis Annals of Oncology ·Alberto Bongiovanni, Chiara Liverani, Flavia Foca, Yogendra Bhati, Federica Pieri, Qianqian Zong, Riccardo Galassi, Davide Cavaliere, Stefano Severi, Valentina Fausti, Giandomenico Di Menna, Laura Mercatali, Alessandro De Vita, Nada Riva, Sebastiano Calpona, Giacomo Miserocchi, Chiara Spadazzi, Toni Ibrahim	2020	1
9	BOne HEalth ManagEment in Patients with Early Breast Cancer: A Retrospective Italian Osteoncology Center “Real-Life” Experience (BOHEME Study) Journal of Clinical Medicine ·Federica Recine, Alberto Bongiovanni, Flavia Foca, Laura Mercatali, Valentina Fausti, Sebastiano Calpona, Nada Riva, Alessandro De Vita, Chiara Liverani, Chiara Spadazzi, Giacomo Miserocchi, Giandomenico Di Menna, Lorena Gurrieri, Claudia Cocchi, Lianlong Wu, Roberto Vespignani, Toni Ibrahim	2019	4
10	Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas OncoTargets and Therapy ·Federica Recine, Alberto Bongiovanni, Nada Riva, Valentina Fausti, Alessandro De Vita, Laura Mercatali, Chiara Liverani, Giacomo Miserocchi, Dino Amadori, Toni Ibrahim	2017	25
11	Primary leiomyosarcoma of the bone Medicine ·Federica Recine, Alberto Bongiovanni, Roberto Casadei, Federica Pieri, Nada Riva, Alessandro De Vita, Laura Mercatali, Chiara Liverani, Chiara Spadazzi, Giacomo Miserocchi, Valentina Fausti, Dino Amadori, Toni Ibrahim	2017	15
12	RANKL: A promising circulating marker for bone metastasis response Oncology Letters ·Toni Ibrahim, Marianna Ricci, Emanuela Scarpi, Alberto Bongiovanni, 日吉明, Nada Riva, Chiara Liverani, Alessandro De Vita, Federico La Manna, Devil Oboldi, Patrizia Serra, Flavia Foca, Lorenzo Cecconetto, Dino Amadori, Laura Mercatali	2016	25
13	Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas OncoTargets and Therapy ·Alessandro De Vita, Laura Mercatali, Federica Recine, Federica Pieri, Nada Riva, Alberto Bongiovanni, Chiara Liverani, Chiara Spadazzi, Giacomo Miserocchi, Dino Amadori, Toni Ibrahim	2016	65
14	Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model Annals of Oncology ·Chiara Liverani, Federico La Manna, Arwin Groenewoud, Laura Mercatali, Gabri van der Pluijm, Federica Pieri, Davide Cavaliere, Orestes Tejas Sánchez, Chiara Spadazzi, Giacomo Miserocchi, Alberto Bongiovanni, Federica Recine, Nada Riva, D. Amadori, Ennio Tasciotti, 喬石室, Valentina Fausti, B. Ewa Snaar‐Jagalska, Toni Ibrahim	2016	4
15	Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR) Supportive Care in Cancer ·Alberto Bongiovanni, Manuela Monti, Flavia Foca, Federica Recine, Nada Riva, Valentina Di Iorio, Chiara Liverani, Alessandro De Vita, Giacomo Miserocchi, Laura Mercatali, Dino Amadori, Toni Ibrahim	2016	5
16	Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of 18FDG-PET/CT Clinical Lung Cancer ·Alberto Bongiovanni, Federica Recine, Nada Riva, Flavia Foca, Chiara Liverani, Laura Mercatali, Silvia Nicolini, Federica Pieri, Dino Amadori, Toni Ibrahim	2016	26
17	First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma OncoTargets and Therapy ·Alberto Bongiovanni, Nada Riva, Marianna Ricci, Chiara Liverani, Federico La Manna, Alessandro De Vita, Toni Ibrahim, Flavia Foca, Laura Mercatali, Dino Amadori, Perkash Lal	2015	30
18	Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report BMC Cancer ·Alberto Bongiovanni, Nada Riva, Marianna Ricci, Laura Mercatali, Chiara Liverani, Federico La Manna, Alessandro De Vita, Davide Cavaliere, Federica Pieri, Devil Oboldi, Giorgio Maria Verdecchia, Dino Amadori, Toni Ibrahim	2015	5
19	CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems Bone ·Chiara Liverani, Laura Mercatali, Chiara Spadazzi, Federico La Manna, Alessandro De Vita, Nada Riva, Sebastiano Calpona, Marianna Ricci, Alberto Bongiovanni, Đặng Văn Đức, Michele Zanoni, Francesco� Fabbri, Wainer Zoli, Dino Amadori, Toni Ibrahim	2014	31
20	Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally ill cancer patients European Journal of Cancer ·Marco Maltoni, Oriana Nanni, Stefania Derni, 楠尊行, Laura Fabbri, Nada Riva, Roberta Maltoni, D. Amadori	1994	76

About Nada Riva

Nada Riva is a scholar working on Oncology, Neurology, Gastroenterology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 32 papers that have together received 592 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (14 papers), Neuroendocrine Tumor Research Advances (9 papers), Neuroblastoma Research and Treatments (8 papers), Vascular Tumors and Angiosarcomas (7 papers), Lung Cancer Research Studies (7 papers), Cardiac tumors and thrombi (5 papers), Bone health and treatments (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). The work is most often cited by research in Oncology (362 citations), Pulmonary and Respiratory Medicine (271 citations), Neurology (92 citations), Rheumatology (77 citations) and Epidemiology (122 citations). Nada Riva has collaborated with scholars based in Italy, Netherlands and United Kingdom. Frequent co-authors include Toni Ibrahim, Chiara Liverani, Laura Mercatali, Alberto Bongiovanni, Alessandro De Vita, Dino Amadori, Giacomo Miserocchi, Chiara Spadazzi, Federica Pieri and Federica Recine. Their work appears in journals such as OncoTargets and Therapy, Medicine, International Journal of Molecular Sciences, Annals of Oncology and Therapeutic Advances in Medical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact